...

Treatment Update

PrEP and My Patients: Guidance for LGBT Community–Based Primary Care Providers on Novel Strategies to Reduce Risk of HIV Acquisition


Downloadable PowerPoint Slideset:

PrEP and My Patients: Guidance for LGBT Community–Based Primary Care Providers on Novel Strategies to Reduce Risk of HIV Acquisition
Expert faculty Jared Baeten, MD, PhD; Susan Buchbinder, MD; Connie L. Celum, MD, MPH; and Albert Liu, MD, MPH review emerging data on pre-exposure prophylaxis and antiretroviral therapy as prevention and discuss implications for community providers.

Treatment Update

Advances in Preventing HIV Transmission Using Antiretroviral Therapy: The Role of OB/GYNs 


Downloadable PowerPoint Slideset:

Advances in Preventing HIV Transmission Using Antiretroviral Therapy: The Role of OB/GYNs
In this downloadable slideset, Jean R. Anderson, MD, provides OB/GYNs, who are already familiar with the concept of antiretroviral therapy as prevention, with an an update of recent data that have demonstrated broader applications for the use of anti-HIV treatment as prevention.

Downloadable PDF's:

Guidance on HIV Testing in Women
Download this quick-reference PDF for guidance on HIV testing and counseling in both pregnant and nonpregant women.

Guidance on the Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission
Download this quick-reference PDF for guidance on recommended agents for use in pregnancy to prevent mother-to-child HIV transmission.

Guidance on Prevention of HIV Transmission in Serodiscordant Couples
Download this quick-reference PDF for guidance on the use of antiretroviral therapy in both the HIV-positive and HIV-negative persons in serodiscordant couples.

Treatment Update

Keeping It Simple: Treatment Simplification in HIV Management


Now Available!

CME-Certified Interactive Virtual Presentation:

Keeping It Simple: Treatment Simplification in HIV Management
Santiago Moreno, MD, PhD, and Stefano Vella, MD, provide an in-depth, case-based review of key considerations and evidence-based strategies for simplifying HIV treatment.


Downloadable PowerPoint Slideset:

Keeping It Simple: Treatment Simplification in HIV Management
Santiago Moreno, MD, PhD, and Stefano Vella, MD, provide an in-depth, case-based review of key considerations and evidence-based strategies for simplifying HIV treatment.

Treatment Update

Starting Antiretroviral Therapy in 2012: A Compendium of Interactive Cases 


CME-Certified Interactive Virtual Presentation:

/upload/global/headshots/eron_joseph.jpg/upload/global/headshots/squires_kathleen.jpg

Starting Antiretroviral Therapy in 2012: A Compendium of Interactive Cases
Joseph J. Eron, Jr., MD, and Kathleen E. Squires, MD, challenge you to manage several patients who are candidates for first-line antiretroviral therapy. See if you make the same choices that they do!

Downloadable PowerPoint Slideset:

Starting Antiretroviral Therapy in 2012
Expert faculty Joseph J. Eron, Jr., MD, and Kathleen E. Squires, MD, review considerations for first-line therapy and the considerations for tailoring therapy illustrated by a group of 6 patient cases.

Treatment Update

Emerging Issues in First-line Antiretroviral Therapy


CME-Certified Interactive Video Module:

/upload/global/headshots/gallant_joel.jpg/upload/global/headshots/hicks_charles.jpg

Emerging Issues in First-line Antiretroviral Therapy
Joel E. Gallant, MD, MPH, and Charles B. Hicks, MD, review timing and choice of first-line antiretroviral therapy in this unique program with a didactic video module and several case-based vignettes in which you are invited to help manage the patient.


Downloadable PowerPoint Slideset:

Emerging Issues in First-line Antiretroviral Therapy
Expert faculty Joel E. Gallant, MD, MPH, and Charles B. Hicks, MD, review considerations for first-line therapy and how emerging data are changing the landscape for treatment of naive patients.

Conference Coverage

2012 Conference on Retroviruses and Opportunistic Infections

CCO’s independent conference coverage of the Conference on Retroviruses and Opportunistic Infections in Seattle, Washington, includes Capsule Summaries of the most clinically relevant data presented at the meeting and an original CCO CME/CE-certified downloadable slideset that includes faculty analyses of the presented data.


Capsule Summaries


CME-Certified PowerPoint Slideset:

HIV Highlights From Seattle
In this CME-certified slideset, Joseph J. Eron, Jr., MD, and Kimberly Y. Smith, MD, MPH, discuss the clinical implications of new data presented at the 2012 Conference on Retroviruses and Opportunistic Infections.

Downloadable PowerPoint Slideset:

/upload/global/headshots/eron_joseph.jpg/upload/global/headshots/smith_kimberly.jpg

HIV Highlights From Seattle
Joseph J. Eron, Jr., MD, and Kimberly Y. Smith, MD, MPH, review the most clinically relevant studies presented at this important annual conference.

Conference Coverage

2011 International Conference on AIDS and STIs in Africa (ICASA)

CCO's Independent Conference Coverage of the 2011 International Conference on AIDS and STIs in Africa (ICASA) includes a Conference Report that focuses on key issues highlighted at the conference.


Conference Report:

ICASA 2011 Conference Report
In this Conference Report, Meg C. Doherty, MD, MPH, PhD, and Jean B. Nachega, MD, PhD, discuss the clinical implications of key data presented at the 16th International Conference on AIDS and STIs in Africa.

Treatment Update

Treatment Tradeoffs: Weighing the Benefits and Risks When Individualizing First-line Antiretroviral Therapy


CME-Certified Interactive Virtual Presentation:

/upload/global/headshots/arribas_jose.jpg/upload/global/headshots/pozniak_anton.jpg

Treatment Tradeoffs: Weighing the Benefits and Risks When Individualizing First-line Antiretroviral Therapy
José R. Arribas, MD, and Anton L. Pozniak, MD, FRCP, review the recommended/preferred and alternative options for initial therapy and discuss how the ideal regimen can be chosen for each patient by an individualized assessment of the advantages and disadvantages of each regimen.

Downloadable PowerPoint Slideset:

Treatment Tradeoffs: Weighing the Benefits and Risks When Individualizing First-line Antiretroviral Therapy
Jose R. Arribas, MD, and Anton L. Pozniak, MD, FRCP, discuss the construction of individualized initial antiretroviral regimens based on “trading off” advantages and disadvantages of the agents in the regimen.

Conference Coverage

2011 European AIDS Conference

CCO's Independent Conference Coverage of the 2011 European AIDS conferenceincludes a CME-Certified Slideset and Downloadable Slides that focus on key issues highlighted at the conference.


HIV/AIDS Highlights From Belgrade 2011

Downloadable PowerPoint Slideset:

HIV/AIDS Highlights From Belgrade 2011
William G. Powderly, MD, and Peter Reiss, MD, PhD, review the most clinically relevant studies presented at this important biannual European conference.

Treatment Update

CCO HIV Stay Tuned

Bimonthly CME-certified audio Podcasts, each supported by a variety of online resources.

Implementing Best Practices in HIV Patient Care—Volume 4, Edition 2

In this edition of Stay Tuned:
  • A Must Read: Real-World Outcomes of Antiretroviral Therapy in a Challenging Patient Population
    Kimberly Y. Smith, MD, MPH, and Andrew R. Zolopa, MD, discuss virologic suppression in a Baltimore city cohort and implications for real-world management of HIV.
  • Case of the Month: Decision Making for the Initiation of HCV Treatment in an HIV-Coinfected Patient
    Susanna Naggie, MD, reviews a patient case involving an HIV/HCV-coinfected patient and discusses factors relevant for the initiation and choice of HCV therapy.
  • Expert Viewpoint: Evolving Options for NNRTIs in Antiretroviral Regimens
    Kimberly Y. Smith, MD, MPH, and Joel E. Gallant, MD, MPH, discuss new guideline recommendations for the choice of NNRTIs in antiretroviral regimens

Audio, video, and slideset downloads are also provided for additional reference. Click here to start.

Treatment Update

Preparing for PrEP: Answers for LGBT Community–Based Primary Care Practices on Emerging Strategies to Reduce Risk of HIV Acquisition


Downloadable Slideset:

Preparing for PrEP: Answers for LGBT Community–Based Primary Care Practices on Emerging Strategies to Reduce Risk of HIV Acquisition
Review emerging data on pre-exposure prophylaxis and antiretroviral therapy as prevention with expert faculty Jared Baeten, MD, PhD; Susan Buchbinder, MD; Connie L. Celum, MD, MPH; and Albert Liu, MD, MPH.

Conference Coverage

CCO Independent Conference Coverage of the 2011 Interscience Conference on Antimicrobial Agents and Chemotherapy 

CCO's Independent Conference Coverage of the 2011 Interscience Conference on Antimicrobial Agents and Chemotherapy meeting includes Conference Report, and Downloadable Slides that focus on key issues highlighted at the conference.


CME-Certified Conference Report:

/upload/global/headshots/eron_joseph.jpg/upload/global/headshots/gallant_joel.jpg

From Podium to Practice: HIV Highlights From Chicago
In this CME-certified Conference Report, Joseph J. Eron, Jr., MD, and Joel E. Gallant, MD, MPH, discuss the clinical implications of key findings related to HIV-1 and hepatitis C virus infection presented at the 2011 Interscience Conference on Antimicrobial Agents and Chemotherapy.

Downloadable Powerpoint Slideset:

HIV/AIDS Highlights From Chicago 2011
Join expert faculty members W. David Hardy, MD, and Kathleen E. Squires, MD, for a review of the HIV highlights of this important annual conference.

Annual Update

HIV and Hepatitis C Annual Update 2011

Expert faculty members review scientific and clinical advances of the past year.


Now Available!

CME/CE-Certified Modules:

/upload/global/headshots/sulkowski_mark.jpg

Direct-Acting Antivirals in Treatment-Naive HCV Patients
Mark S. Sulkowski, MD, reviews the latest data on and the approved indications of telaprevir and boceprevir in treatment-naive, genotype 1 HCV–infected patients.

/upload/global/headshots/gallant_joel.jpg

Recent Advances in Antiretroviral Therapy
Joel E. Gallant, MD, MPH, reviews state-of-the-art management of antiretroviral therapy and discusses the clinical implication of recent data for HIV-infected patients.

/upload/global/headshots/ray_stuart.jpg

HCV Resistance: Similarities and Differences With HIV 
Stuart Ray, MD, reviews key similarities and differences between the life cycles and resistance mechanisms of HCV and HIV and explores how these features may impact HCV treatment with newly approved direct-acting antiviral agents.

Healthcare Reform and HIV Care
Michael T. Wong, MD, discusses the healthcare reform measures of 2010 and potential impact on HIV treatment.

/upload/global/headshots/jacobson_ira.jpg

Direct-Acting Antivirals in Treatment-Experienced HCV Patients
Ira M. Jacobson, MD, reviews the key data and optimal use of protease inhibitor therapy in treatment-experienced individuals with HCV infection.

Management of Aging HIV-Infected Patients
Amy C. Justice, MD, MSc, PhD, discusses the aspects of HIV management affected by aging and describes use of the VACS Index, a tool that may be used to stratify risk in aging patients.


Downloadable Powerpoint Slideset:

2011 HIV/Hepatitis C Annual Update
Download this slideset of selected key figures and tables from the CCO HIV and Hepatitis C Annual Update for use in your personal noncommercial presentations.

Conference Coverage

2011 IAS Conference on HIV Pathogenesis, Treatment and Prevention 

CCO's Official Conference Coverage of the 2011 IAS Conference on HIV Pathogenesis, Treatment and Prevention meeting includes Capsule Summaries of key presentations, as well as Expert Analysis, Conference Report, Downloadable Slides, and audio Expert Highlights that focus on key issues highlighted at the conference.


From Podium to Practice: Clinical Impact of New Data From IAS 2011  
Anton L. Pozniak, MD, FRCP; Ian M. Sanne, MBBCH, FCP(SA); Kimberly Y. Smith, MD, MPH


Clinical Studies in Resource-Limited Settings  
Beatriz Grinsztejn, MD, PhD; Jean B. Nachega, MD, PhD


Now Available!

Downloadable Powerpoint Slideset:

HIV/AIDS Highlights From Rome
In this downloadable slideset, Eric S. Daar, MD, and Joel E. Gallant, MD, MPH, review key studies from the 2011 International AIDS Society conference.

CME-Certified Expert Analysis:

/upload/global/headshots/pozniak_anton.jpg/upload/global/headshots/sanne_ian.jpg/upload/global/headshots/smith_kimberly.jpg

From Podium to Practice: Clinical Impact of New Data From IAS 2011
Review data from this important international meeting with expert faculty Anton L. Pozniak, MD, FRCP; Ian M. Sanne, MBBCH, FCP(SA); and Kimberly Y. Smith, MD, MPH, and see how they would apply this information to care of their HIV-infected patients.


CME/CE-Certified Conference Report:

IAS 2011 Conference Report: Clinical Studies in Resource-Limited Settings
Beatriz Grinsztejn, MD, PhD, and Jean Nachega, MD, PhD, discuss the challenges and forward momentum of HIV treatment in resource-limited settings, particularly sub-Saharan Africa.

Expert Viewpoint

The Evolving Role of Stavudine as Part of Initial Antiretroviral Therapy in Resource-Constrained Settings 


Now Available!

Expert Viewpoint:

The Evolving Role of Stavudine as Part of Initial Antiretroviral Therapy in Resource-Constrained Settings
Arnaldo David Casiró, MD, a local physician and clinical trial investigator in Buenos Aires, Argentina, discusses the current role of stavudine as part of first-line antiretroviral therapy in resource-limited settings as well as the barriers to modifying stavudine-containing regimens.

Treatment Update

Answering the Questions: Why and How to Implement Routine HIV Testing in Primary Care Settings

Experts address frequently asked questions in CME modules, downloadable slides.


Now Available!

CME/CE-Certified Modules:

Answering the Questions: Implementing Routine HIV Testing in Primary Care Settings
In this CME/CE-certified learning module, C. Bradley Hare, MD; Donna Futterman, MD; and Alice C. Thornton, MD, AAHIVS, answer the most frequently asked questions on best strategies and key considerations for implementing routine HIV testing in clinical practice.

Faculty Responses to Additional Questions on Routine Testing for HIV Infection in Primary Care Settings 
In this CME/CE-certified learning module, C. Bradley Hare, MD; Donna Futterman, MD; and Alice C. Thornton, MD, AAHIVS, answer the most compelling questions posed by readers on the implementation of routine HIV testing in primary care settings.


Downloadable Powerpoint Slideset:

Answering the Questions: Why and How to Implement Routine HIV Testing in Primary Care Settings
Program faculty Donna Futterman, MD, C. Bradley Hare, MD, and Alice C. Thornton, MD, AAHIVS, review data supporting early diagnosis of HIV and provide practical insight into implementing routine testing strategies into clinical practice.

 

Treatment Update

Building a Bridge to Better HIV Care


Downloadable Slideset:

Building a Bridge to Better HIV Care
Kathleen E. Squires, MD, Alice C. Thornton MD, AAHIVS, and expert faculty review steps appropriate for management of the HIV-infected patient at various points in the treatment spectrum in this practical, guidelines-supported slideset..



Quickly access answers to your point-of-care questions



LATEST UPDATES:

Overview of HIV Prevention: Updated to reflect data presented at the 2010 Retroviruses meeting in San Francisco, California.

Management of HIV-Exposed and HIV-Infected Children: Updated with new data on the use of raltegravir in pediatric patients.

Browse HIV

New Data

Study 183-0145: Elvitegravir Noninferior to Raltegravir in Treatment-Experienced Patients Receiving Optimized Boosted PI–Based Regimen


In treatment-experienced HIV-infected patients receiving a boosted PI–containing optimized background regimen, elvitegravir was noninferior to raltegravir at Week 48, with a similar overall frequency of adverse events.


Click here for related capsule summaries

Expert Commentary

from our Advisory Board & leading experts

Journal Options for June 2010

By:

Myron S. Cohen, MD

Myron S. Cohen, MD

Associate Vice Chancellor
J. Herbert Bate Distinguished Professor
Medicine,
Microbiology and Immunology and Public Health
Director, UNC Institute for Global Health and Infectious Disease
Chief, Division of Clinical Infectious Disease
University of North Carolina Chapel Hill
Chapel Hill, North Carolina

More Journal Options